Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-07-27 Purchase | 2023-07-31 07:59 am | Better Therapeutics Inc. | BTTX | PERRY DAVID P Executive Chairman 10% Owner | 1,233,045 | $0.7299 | $900,000 | 17,082,779 (Indirect Direct) | View |
| 2023-07-27 Purchase | 2023-07-31 07:59 am | Better Therapeutics Inc. | BTTX | Berman Mark A. Chief Medical Officer | 54,802 | $0.7299 | $40,000 | 388,191 (Direct) | View |
| 2023-07-27 Purchase | 2023-07-31 07:58 am | Better Therapeutics Inc. | BTTX | Armanino Andrew J. Director | 274,010 | $0.7299 | $200,000 | 741,702 (Indirect Direct) | View |
| 2023-07-27 Purchase | 2023-07-31 07:58 am | Better Therapeutics Inc. | BTTX | Granger Elder Director | 34,251 | $0.7299 | $25,000 | 35,851 (Direct) | View |
| 2023-07-27 Purchase | 2023-07-31 07:58 am | Better Therapeutics Inc. | BTTX | KARBE FRANK Chief Executive Officer | 137,005 | $0.7299 | $100,000 | 429,429 (Direct) | View |
| 2023-07-27 Purchase | 2023-07-31 07:58 am | Better Therapeutics Inc. | BTTX | Parker Geoffrey M. Director | 685,025 | $0.7299 | $500,000 | 1,081,388 (Indirect Direct) | View |
| 2023-05-16 Purchase | 2023-05-18 07:11 am | Better Therapeutics Inc. | BTTX | Granger Elder Director | 600 | $0.8672 | $520 | 1,600 (Direct) | View |
| 2023-04-10 Purchase | 2023-04-12 9:44 pm | Better Therapeutics Inc. | BTTX | PERRY DAVID P David P. Perry 2015 Trust See Remarks 10% Owner | 4,969,697 | $0.825 | $4,100,000 | 4,052,386 (Indirect Direct) | View |
| 2023-04-10 Purchase | 2023-04-12 4:15 pm | Better Therapeutics Inc. | BTTX | KARBE FRANK See Remarks | 242,424 | $0.825 | $200,000 | 292,424 (Direct) | View |
| 2023-04-10 Purchase | 2023-04-12 4:15 pm | Better Therapeutics Inc. | BTTX | Parker Geoffrey M. Director | 303,030 | $0.825 | $250,000 | 396,363 (Indirect Direct) | View |
| 2023-04-10 Purchase | 2023-04-12 4:15 pm | Better Therapeutics Inc. | BTTX | Armanino Andrew J. Director | 303,030 | $0.825 | $250,000 | 467,692 (Indirect Direct) | View |
| 2022-09-15 Purchase | 2022-09-19 06:06 am | Better Therapeutics Inc. | BTTX | PERRY DAVID P David P. Perry 2015 Trust See Remarks 10% Owner | 50,000 | $2.052 | $102,598 | 10,880,037 (Indirect Direct) | View |
| 2022-09-15 Purchase | 2022-09-15 8:53 pm | Better Therapeutics Inc. | BTTX | KARBE FRANK See Remarks | 50,000 | $2.0939 | $104,695 | 50,000 (Direct) | View |
| 2022-09-12 Purchase | 2022-09-14 4:37 pm | Better Therapeutics Inc. | BTTX | Heinen Mark See Remarks | 50,000 | $1.94 | $97,000 | 72,281 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-09 Option Award | 2024-02-13 9:50 pm | N/A N/A | Better Therapeutics Inc. | BTTX | PERRY DAVID P David P. Perry 2015 Trust Executive Chairman 10% Owner | 839,895 | $0.1905 | 19,397,877 (Direct) | View |
| 2024-01-09 Option Award | 2024-01-10 4:19 pm | N/A N/A | Better Therapeutics Inc. | BTTX | PERRY DAVID P Executive Chairman 10% Owner | 1,471,453 | $0.1699 | 18,557,982 (Direct) | View |
| 2023-12-18 Option Award | 2023-12-20 5:24 pm | N/A N/A | Better Therapeutics Inc. | BTTX | PERRY DAVID P Executive Chairman 10% Owner | 3,750 | $0 | 17,086,529 (Direct) | View |
| 2023-12-18 Option Award | 2023-12-20 5:24 pm | N/A N/A | Better Therapeutics Inc. | BTTX | Carmona Richard H Director | 3,750 | $0 | 157,369 (Direct) | View |
| 2023-12-18 Option Award | 2023-12-20 5:23 pm | N/A N/A | Better Therapeutics Inc. | BTTX | LAVIZZO-MOUREY RISA J Director | 3,750 | $0 | 13,750 (Direct) | View |
| 2023-12-18 Option Award | 2023-12-20 5:23 pm | N/A N/A | Better Therapeutics Inc. | BTTX | Wynholds Kristin Chief Product Officer | 25,362 | $0 | 225,631 (Direct) | View |
| 2023-12-18 Option Award | 2023-12-20 5:22 pm | N/A N/A | Better Therapeutics Inc. | BTTX | Parker Geoffrey M. Director | 3,750 | $0 | 1,085,138 (Direct) | View |
| 2023-12-18 Option Award | 2023-12-20 5:22 pm | N/A N/A | Better Therapeutics Inc. | BTTX | Armanino Andrew J. Director | 3,750 | $0 | 745,452 (Direct) | View |
| 2023-12-18 Option Award | 2023-12-20 5:21 pm | N/A N/A | Better Therapeutics Inc. | BTTX | Miller Leslie A. Principal Accounting Officer | 3,587 | $0 | 17,937 (Direct) | View |
| 2023-12-18 Option Award | 2023-12-20 5:15 pm | N/A N/A | Better Therapeutics Inc. | BTTX | Granger Elder Director | 3,750 | $0 | 39,601 (Direct) | View |
| 2023-12-18 Option Award | 2023-12-20 5:13 pm | N/A N/A | Better Therapeutics Inc. | BTTX | KARBE FRANK Chief Executive Officer | 62,500 | $0 | 526,516 (Direct) | View |
| 2023-12-18 Option Award | 2023-12-20 5:10 pm | N/A N/A | Better Therapeutics Inc. | BTTX | Berman Mark A. Chief Medical Officer | 25,362 | $0 | 448,140 (Direct) | View |
Ownership | 2023-12-07 8:09 pm | N/A N/A | Better Therapeutics Inc. | BTTX | Miller Leslie A. Principal Accounting Officer | 0 | $0 | 51,200 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 6:56 pm | N/A 2033-06-06 | Better Therapeutics Inc. | BTTX | Carmona Richard H Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 6:56 pm | N/A 2033-06-06 | Better Therapeutics Inc. | BTTX | Granger Elder Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 6:56 pm | N/A 2033-06-06 | Better Therapeutics Inc. | BTTX | Armanino Andrew J. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 6:55 pm | N/A 2033-06-06 | Better Therapeutics Inc. | BTTX | LAVIZZO-MOUREY RISA J Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 6:55 pm | N/A 2033-06-06 | Better Therapeutics Inc. | BTTX | Parker Geoffrey M. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 6:54 pm | N/A 2033-06-06 | Better Therapeutics Inc. | BTTX | PERRY DAVID P Executive Chairman 10% Owner | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-03-01 Option Award | 2023-04-21 6:14 pm | N/A 2033-02-28 | Better Therapeutics Inc. | BTTX | Heinen Mark Chief Financial Officer | 82,550 | $0 | 170,554 (Direct) | View |
| 2023-03-01 Option Award | 2023-04-21 6:13 pm | N/A 2033-02-28 | Better Therapeutics Inc. | BTTX | Wynholds Kristin Chief Product Officer | 202,900 | $0 | 301,719 (Direct) | View |
| 2023-03-01 Option Award | 2023-04-21 6:13 pm | N/A 2033-02-28 | Better Therapeutics Inc. | BTTX | Berman Mark A. Chief Medical Officer | 202,900 | $0 | 434,839 (Direct) | View |
Ownership | 2023-04-17 4:15 pm | N/A N/A | Better Therapeutics Inc. | BTTX | Georgianna Maule-Ffinch 2015 Trust 10% Owner | 0 | $0 | 3,636,364 (Direct) | View |
| 2022-05-31 Option Award | 2022-12-02 4:15 pm | N/A N/A | Better Therapeutics Inc. | BTTX | Wynholds Kristin Chief Product Officer | 5,023 | $1.5385 | 98,819 (Direct) | View |
| 2022-11-30 Option Award | 2022-12-02 4:15 pm | N/A N/A | Better Therapeutics Inc. | BTTX | Wynholds Kristin Chief Product Officer | 3,781 | $1.241 | 98,819 (Direct) | View |
| 2022-11-30 Option Award | 2022-12-02 4:15 pm | N/A N/A | Better Therapeutics Inc. | BTTX | Heinen Mark See Remarks | 15,723 | $1.241 | 88,004 (Direct) | View |
| 2022-07-05 Option Award | 2022-07-07 4:32 pm | N/A 2032-07-04 | Better Therapeutics Inc. | BTTX | KARBE FRANK See Remarks | 472,200 | $0 | 472,200 (Direct) | View |